Literature DB >> 7414709

Primary malignant neoplasms associated with chronic lymphocytic leukemia.

A Santoro, F Rilke, F Franchi, S Monfardini.   

Abstract

Over the past 2 decades there has been an almost exponential increase in the frequency with which cases of leukemia associated with another primary malignant lesion have been reported. In this study we reported the occurrence of a second primary neoplasm to 82 consecutive cases of chronic lymphocytic leukemia (CLL) admitted to the Istituto Nazionale Tumori of Milan from September 1962 to December 1978. In 16 of these (19.5%), an assoicated neoplasm was diagnosed subsequently (8 cases) or concurrently (8 cases) to CLL. Head and neck carcinomas and breast cancer had the highest incidence (5 and 3 cases, respectively). The results of this study further support the hypothesis that patients with CLL are prone to develop subsequent cancer. The defective cellular and humoral immunity in CLL may have an etiological role in the development of an additional primary malignancy. Although alkylating agents are known carcinogens in experimental animals and man, our results support the lack of a correlation between treatment with alkylating agents and incidence of second primary neoplasms, as demonstrated by Greene et al. (10).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7414709     DOI: 10.1177/030089168006600404

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  10 in total

1.  Chronic lymphocytic leukemia and breast cancer as synchronous primary in a male-a rare combination.

Authors:  B Dubashi; A Jain; K Srinivasan; V Surendrakumar; S Vivekanandam
Journal:  Curr Oncol       Date:  2011-04       Impact factor: 3.677

2.  Small lymphocytic lymphoma obscuring microscopic tonsillar squamous cell carcinoma: an unknown occurrence with a known primary.

Authors:  Eugen C Minca; Saurin R Popat; Manpreet K Chadha; Mihai Merzianu
Journal:  Head Neck Pathol       Date:  2010-12-01

3.  Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus.

Authors:  Joseph M Flynn; Leslie Andritsos; David Lucas; John C Byrd
Journal:  Br J Haematol       Date:  2010-03-08       Impact factor: 6.998

4.  Occurrence of second neoplasms in chronic lymphocytic leukemia. Experience at Padua Hospital between 1979 and 1991.

Authors:  G Bertoldero; G Scribano; L Podda; R Berti; G Amadori
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

Review 5.  Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia.

Authors:  Constantin A Dasanu; Doru T Alexandrescu
Journal:  MedGenMed       Date:  2007-11-15

6.  Cutaneous metastasis of gallbladder adenocarcinoma in a patient with chronic lymphocytic leukemia: a case report and review of the literature.

Authors:  Ozgur Tanriverdi; Nezih Meydan; Sabri Barutca; Gurhan Kadikoylu; Gokhan Sargin; Canten Tataroglu; Nil Culhaci
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

7.  Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.

Authors:  Ohad Benjamini; Preetesh Jain; Long Trinh; Wei Qiao; Sara S Strom; Susan Lerner; Xuemei Wang; Jan Burger; Alessandra Ferrajoli; Hagop Kantarjian; Susan O'Brien; William Wierda; Zeev Estrov; Michael Keating
Journal:  Leuk Lymphoma       Date:  2014-11-19

8.  Colonic involvement in a patient with chronic lymphocytic leukaemia.

Authors:  P E T Arkkila; H Nuutinen; F Ebeling; E Elonen; P Kärkkäinen; M-L Karjalainen-Lindsberg
Journal:  Gastroenterol Res Pract       Date:  2008       Impact factor: 2.260

Review 9.  Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.

Authors:  Silvia Sánchez-Ramón; Fatima Dhalla; Helen Chapel
Journal:  Front Immunol       Date:  2016-08-22       Impact factor: 7.561

Review 10.  Second neoplasms in patients with chronic lymphocytic leukemia.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2004-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.